The U.S. Centers for Disease Control and Prevention finally has a permanent leader at the helm. Following a 51–44 Senate vote on August 5, Dr. Erica Schwartz was confirmed as the agency’s 22nd director. The milestone makes her the CDC’s first Senate-confirmed leader in nearly a year, and the first Black woman in history to lead the nation’s premier public health agency.

Schwartz, a 54-year-old public health veteran holding medical, legal, and public health degrees, spent 24 years in the U.S. Public Health Service Commissioned Corps and previously served as Deputy Surgeon General. Her confirmation arrives at a critical juncture for an agency battered by internal turmoil, severe staffing cuts, and mounting public health threats.

The CDC has operated without a permanent director since August 2025 following leadership disputes over federal health directives.

A rotating roster of interim acting directors held the reins while workforce reductions and high-profile resignations depleted CDC staff by nearly a third over the past year. Public health experts across the country voiced urgent concern over the prolonged lack of permanent oversight, warning that a ship without a captain cannot effectively respond to emerging crises or maintain clear public guidance.

Dr. Schwartz steps into the post as the country faces several active public health threats requiring rapid, coordinated federal action.

Domestically, the CDC is investigating a 15-state cyclosporiasis outbreak linked to fresh produce, alongside a widespread Salmonella outbreak tied to commercial egg recalls. At the same time, widespread measles transmission continues to pose a serious challenge across multiple U.S. regions amid shifting vaccination rates. On the global stage, federal health officials are also closely monitoring a surging Ebola outbreak in the Democratic Republic of the Congo.

With two decades of frontline experience, Schwartz brings an operational approach to an agency in desperate need of stability. During confirmation hearings, she pledged to demonstrate “radical transparency and unwavering scientific integrity” while keeping evidence-based public health at the core of every policy decision.

Her immediate priorities center on rebuilding staff morale, restoring public trust in CDC recommendations, and supporting state health departments.